Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate versus delayed entecavir for active chronic hepatitis B and liver fibrosis
2010-018523-26Phase 4Terminated
- Sponsor
- ASST Spedali Civili di Brescia
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of entecavir in Chronic Hepatitis B (CHB) (2 arms), sponsored by ASST Spedali Civili di Brescia. Primary endpoints: Anti-HBe seroconversion in baseline HBeAg-positive subjects, HBsAg loss and HBs seroconversion and 7 more. Started Mar 2010; status: terminated.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2010-018523-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018523-26.